580
Participants
Start Date
April 30, 2008
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
levocetirizine dihydrochloride
5 mg daily (oral tablet) for 14 days
placebo
0 mg daily (matching oral tablet) for 14 days
Tucson
Los Angeles
Sacramento
San Francisco
San Jose
Colorado Springs
Denver
Miami
Atlanta
Gainesville
Lawrenceville
Stockbridge
Normal
Louisville
Harvard
North Dartmouth
Novi
Minneapolis
Berlin
Skillman
Verona
Rochester
Asheville
Charlotte
Wilmington
Cincinnati
Edmond
Oklahoma City
Portland
Pittsburgh
Upland
Lincoln
Germantown
San Antonio
Salt Lake City
South Burlington
Arlington
Milwaukee
Lead Sponsor
UCB Pharma
INDUSTRY